Reliability of the Five Step Assessment and Its Coefficients of Impairment in Spastic Paresis

五步评估法的可靠性及其在痉挛性轻瘫中的损伤系数

阅读:2

Abstract

OBJECTIVE: To determine the intrarater and interrater reliability of the Five Step Assessment (FSA) and its derived coefficients of impairment in chronic spastic paresis. DESIGN: Prospective observational study. SETTING: Study of outpatients followed in a rehabilitation department. PARTICIPANTS: In this single-center prospective study, participants (n=18) with chronic hemiparesis (>1y since injury) were evaluated by 4 raters (3 medical doctors, 1 physiotherapist; experience in hemiparesis, 14±9y). INTERVENTIONS: All raters estimated muscle shortening, spasticity, weakness, and fatigability against the resistance of 8 key antagonists in adults twice, one week apart. MAIN OUTCOME MEASURES: FSA involves measuring 4 angles: angle of arrest at slow speed of stretch (X(V1)), angle of catch or clonus at fast speed of stretch (X(V3), Tardieu), angle of match between maximal agonist effort and passive and active antagonist resistances (X(A)), residual angle of match after 15 seconds of repeated maximal amplitude active efforts (X(A15)), and spasticity grade Y. Four derived coefficients of impairment were studied: coefficients of shortening, C(SH=)(X(N)-X(V1))/X(N) (X(N), normally expected maximal passive joint amplitude); of spasticity, C(SP)=(X(V1)-X(V3))/X(V1); of weakness, C(W)=(X(V1)-X(A))/X(V1); and of fatigability, C(F)=(X(A)-X(A15))/X(A). Both intraclass correlation coefficients and mean differences were calculated for each parameter. RESULTS: Among 18 participants (four women), intrarater reliability was good to excellent (intraclass correlation coefficient >0.75) for all parameters in all muscles. Interrater reliability was good to excellent for all muscles and parameters except for spasticity grade Y and coefficient of fatigability (moderate). CONCLUSIONS: The 5 parameters and 4 coefficients of impairment of the FSA have moderate-to-excellent intrarater and interrater reliability in chronic spastic paresis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。